Coldstream Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Sell |
3,246
-116
| -3% | -$14.6K | 0.01% | 744 |
|
|
2025
Q1 | $460K | Buy |
3,362
+567
| +20% | +$77.6K | 0.01% | 648 |
|
|
2024
Q4 | $427K | Buy |
2,795
+398
| +17% | +$60.9K | 0.01% | 670 |
|
|
2024
Q3 | $459K | Sell |
2,397
-300
| -11% | -$57.5K | 0.01% | 641 |
|
|
2024
Q2 | $625K | Buy |
2,697
+435
| +19% | +$101K | 0.02% | 465 |
|
|
2024
Q1 | $488K | Sell |
2,262
-20
| -0.9% | -$4.31K | 0.01% | 560 |
|
|
2023
Q4 | $591K | Buy |
2,282
+333
| +17% | +$86.2K | 0.02% | 439 |
|
|
2023
Q3 | $501K | Sell |
1,949
-241
| -11% | -$61.9K | 0.02% | 418 |
|
|
2023
Q2 | $624K | Buy |
2,190
+40
| +2% | +$11.4K | 0.02% | 373 |
|
|
2023
Q1 | $598K | Sell |
2,150
-20
| -0.9% | -$5.56K | 0.02% | 378 |
|
|
2022
Q4 | $601K | Buy |
+2,170
| New | +$601K | 0.02% | 369 |
|
|
2022
Q2 | $408K | Buy |
2,002
+799
| +66% | +$163K | 0.02% | 460 |
|
|
2022
Q1 | $253K | Sell |
1,203
-269
| -18% | -$56.6K | 0.01% | 644 |
|
|
2021
Q4 | $353K | Buy |
1,472
+378
| +35% | +$90.6K | 0.01% | 550 |
|
|
2021
Q3 | $310K | Sell |
1,094
-76
| -6% | -$21.5K | 0.02% | 305 |
|
|
2021
Q2 | $405K | Buy |
1,170
+285
| +32% | +$98.7K | 0.02% | 313 |
|
|
2021
Q1 | $248K | Sell |
885
-199
| -18% | -$55.8K | 0.01% | 363 |
|
|
2020
Q4 | $265K | Buy |
+1,084
| New | +$265K | 0.02% | 319 |
|
|
2020
Q3 | – | Sell |
-772
| Closed | -$207K | – | 309 |
|
|
2020
Q2 | $207K | Sell |
772
-44
| -5% | -$11.8K | 0.02% | 291 |
|
|
2020
Q1 | $258K | Sell |
816
-177
| -18% | -$56K | 0.03% | 222 |
|
|
2019
Q4 | $294K | Buy |
993
+99
| +11% | +$29.3K | 0.02% | 258 |
|
|
2019
Q3 | $208K | Buy |
+894
| New | +$208K | 0.02% | 309 |
|
|
2018
Q4 | – | Sell |
-742
| Closed | -$262K | – | 320 |
|
|
2018
Q3 | $262K | Buy |
+742
| New | +$262K | 0.02% | 285 |
|
|
2018
Q1 | – | Sell |
-987
| Closed | -$314K | – | 290 |
|
|
2017
Q4 | $314K | Buy |
987
+225
| +30% | +$71.6K | 0.03% | 236 |
|
|
2017
Q3 | $239K | Buy |
+762
| New | +$239K | 0.03% | 262 |
|